Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis—a pilot study

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) has common risk factors with cancer and significant similarities in the pathobiology process, both diseases having poor outcomes. Immune checkpoint PD-L1 has become the target of checkpoint inhibitory therapy that unleashes antitumor T cells and has re...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Dis
Egile Nagusiak: Jovanovic, Dragana, Roksandic Milenkovic, Marina, Kotur Stevuljevic, Jelena, Markovic, Jelena, Ceriman, Vesna, Kontic, Milica, Skodric Trifunovic, Vesna
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344764/
https://ncbi.nlm.nih.gov/pubmed/30746211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.11.16
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak